Influence of prostaglandin A2 and 2-methoxyestradiol on mitogen-activated protein kinase (MAPK) expression levels in malignant cells lines

Biomedical Research

Volumn 25, Issue 3, 2004, Pages 133-139

  Joubert, Annie ^a   Maritz, Christine ^a   Joubert, Fourie ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE 1; PROSTAGLANDIN A2;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; HELA CELL; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 27244448568     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.25.133     Document Type: Article

References (38)

1. Agarwal ML, Agarwal A, Taylor WR and Stark GR (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92, 8493-8497.
2. Ahn NG, Seger R and Krebs EG (1992) The mitogen-activated protein kinase activator. Curr Opin Cell Biol 6, 992-999.
3. Bregman MD, Funk C and Fukushima M (1986) Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. Cancer Res 46, 2740-2744.
4. De Kock M, Seegers JC and Els HJ (1992) Effects of gammalinolenic acid on mitosis and nuclear morphology in osteogenic sarcoma cells. S Afr Med J 81, 467-472.
5. 1 arrest and preclinical results. Ann N Y Acad Sci 744, 161-165.
6. Habiro A, Tanno S, Koizumi K, Izawa T, Nakano Y, Osanai M, Mizukami Y, Okumura T and Kohgo Y (2004) Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun 316, 71-77.
7. Hii CST, Huang ZH, Bilney A, Costabile M, Murray AW, Rathjen DA, Der CJ and Ferrante A (1998) Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells, HL60 promyelocytic leukemic cells, and human neutrophils. J Biol Chem 273, 19277-19282.
8. Hitomi M, Shu J, Strom D, Hiebert SW, Harter ML and Stacey DW (1996) Prostaglandin A2 blocks the activation of G1 phase cyclin-dependent kinase without altering mitogen-activated protein kinase stimulation. J Biol Chem 271, 9376-9383.
9. 2 and 2-Methoxyestradiol on Telomerase Activity in Cancer Cell Lines and a Non-tumorigenic Epithelial Breast Cell Line. Biomed Res 24, 125-131.
10. 2 on cell growth, cell cycle status and apoptosis induction in HeLa and MCF-7 cells. Cancer Lett 191, 203-209.
11. Joubert AM, Panzer A, Joubert F, Lottering M-L, Bianchi PC and Seegers JC (1999) Comparative study of the effects of polyunsaturated fatty acids and their metabolites on cell growth and tyrosine kinase activity in oesophageal carcinoma cells. Prostaglandins Leukot Essent Fatty Acids 61, 171-182.
12. 2- treated cells in vitro. Prostaglandins Leukot Essent Fatty Acids 65, 173-177.
13. Kikuchi Y, Kita T, Hirata J, Kuki E, Nagata I and Fukushima M (1992) Modulation of human lymphocyte response to phytohemagglutinin by antineoplastic prostaglandins. Int J Immunopharmacol 14, 105-110.
14. Kumar AP, Garcia GE and Slaga TJ (2001) 2-methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells. Mol Carcinog 31, 111-124.
15. Kyriakis JM and Avruch J (1996) Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 271, 24313-24316.
16. LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ and Pribluda VS (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62, 3691-3697.
17. Lee YJ, Kuo HC, Chu CY, Wang CJ, Lin WC and Tseng TH (2003) Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharmacol 66, 2281-2289.
18. Lippert C, Seeger H and Mueck AO (2003) The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci 10, 877-883.
19. Lottering ML, De Kock M, Viljoen TC, Grobler CJ and Seegers JC (1996) 17beta-Estradiol metabolites affect some regulators of the MCF-7 cell cycle Cancer Lett 110, 181-186.
20. Minden A and Karin M (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333, F85-104.
21. Miyoshi N, Uchida K, Osawa T and Nakamura Y (2004) A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Res 64, 2134-2142.
22. Narumiya S and Fukushima M (1986) Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J Pharmacol Exp Ther 239, 500-505.
23. 2 in nuclei. J Pharmacol Exp Ther 242, 306-311.
24. 1-enriched HeLa S3 cells. J Pharmacol Exp Ther 245, 294-298.
25. Robinson M.J and Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 2, 180-186.
26. Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH, Yue WJ (2002) The role of mitogen-activated protein (MAP) kinase in breast cancer. Steroid Biochem Mol Biol 80, 239-256.
27. Schattenberg JM, Wang Y, Rigoli RM, Koop DR and Czaja MJ (2004) CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling. Hepatology 39, 444-455.
28. Seegers JC, Aveling ML, Van Aswegen CH, Cross M, Koch F and Joubert WS (1989) The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. Steroid Biochem 32, 797-809.
29. 2 in cell cycle progression, apoptosis induction, tyrosine- and cdc2-kinase activity in esophageal cancer cells. Prostaglandins Leukot Essent Fatty Acids 62, 75-84.
30. Seegers JC, Lottering M-L, Grobler CJ, Van Papendorp DH, Habbersett RC, Shou Y and Lehnert BE (1997) The mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction in transformed cells but not in normal cells. J Steroid Biochem Mol Biol 62, 253-267.
31. Seger R and Krebs EG (1995) The MAPK signaling cascade. Faseb J 9, 726-735.
32. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW and Greenberg AH (1994) Premature p34cdc-2 activation required for apoptosis. Science 263, 1143-1145.
33. Subbaramaiah K, Hart JC, Norton L and Dannenberg AJ (2000) Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways. J Biol Chem 275, 14838-14845.
34. Thaver V (2003) Mechanism(s) of apoptosis induction by 2-methoxyestradiol, an estrogen metabolite, in SNO and WHCO3 oesophageal carcinoma cell lines. M.Sc. Dissertation, Department of Physiology, University of Pretoria, Pretoria, South Africa.
35. Tinley TL, Leal RM, Randall-Hlubek DA, Cessac JW, Wilkens LR, Rao PN and Mooberry SL (2003) Novel 2-methoxyestradiol analogues with antitumor activity Cancer Res 63, 1538-1549.
36. Wu GS (2004) The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther 3 [Epub ahead of print].
37. Yue T-L, Wang X, Louden CS, Gupta S, Pillarisetti J-L, Hart TK, Lysko PG and Feuerstein GZ (1997) 2- Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: a possible role in stress-activated protein kinase signaling pathway and Fas expression. Mol Pharm 51, 951-962.
38. Zhang Z, Leonard SS, Huang C, Vallyathan V, Castranova V and Shi X (2003) Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic Biol Med 34, 1333-1342.